Lithotripsy Devices Market Size, Share, Growth, and Regional Forecast, 2026 - 2033

The global lithotripsy devices market size is likely to be valued at US$1.7 billion in 2026 and is expected to reach US$2.5 billion by 2033, growing at a CAGR of 5.8% during the forecast period from 2026 to 2033, driven by the expansion of outpatient and ambulatory care, increasing surgical volumes, and adoption of advanced intravascular and extracorporeal lithotripsy technologies.

Global demand for lithotripsy devices is rapidly increasing due to the rising prevalence of kidney stones and peripheral artery disease (PAD), coupled with the growing preference for minimally invasive treatment options.

Driver - Rising Nephrolithiasis Burden Coupled with Advancements in Lithotripsy Technology

The global rise in nephrolithiasis incidence, driven by aging populations, obesity, dehydration, and dietary habits, continues to increase patient volumes and recurrent stone cases.

For instance, the National Kidney Foundation reported that kidney stones lead to over 500,000 emergency room visits every year in the U.S., and roughly one in ten individuals will experience a stone at some point in their lifetime.

This rising disease burden is pushing hospitals and ambulatory centers to adopt faster, minimally invasive stone-management techniques that reduce hospital stay and procedure time, supporting long-term demand for lithotripsy systems.

Technology upgrades such as compact, portable extracorporeal shock wave lithotripsy (ESWL) units, enhanced shock-wave targeting, high-resolution ultrasound/fluoroscopy guidance, and energy-efficient generators are making lithotripsy safer, more precise, and more accessible.

These advancements are expanding adoption in smaller centers, improving treatment accuracy, lowering complications, and strengthening the overall value proposition for both providers and patients.

Restraints - Cost, Clinical, and Competitive Constraints Limiting Wider Adoption

High upfront capital costs for lithotripsy systems, combined with variable reimbursement and notable per-procedure expenses, continue to restrict adoption, particularly for smaller hospitals and ambulatory centers. These financial barriers make it difficult for facilities to justify investment, especially in regions with tighter budgets or inconsistent insurance coverage.

Moreover, lithotripsy faces inherent clinical limitations, such as reduced effectiveness for large, hard, or lower-pole stones and contraindications in certain patient groups. Furthermore, the market faces strong competitive pressure from ureteroscopy and percutaneous nephrolithotomy, which offer higher stone-free rates for complex cases, as well as from improved medical expulsive therapies that reduce the need for device-based intervention.

Opportunity - Smart Imaging Integration and Affordable Portable Devices

Advances in AI-driven imaging, real-time stone tracking, and automated targeting are set to transform treatment precision and workflow efficiency. The integration of intelligent guidance systems with lithotripsy platforms is improving shock-wave accuracy, reducing retreatment rates, and enabling more consistent outcomes. Hybrid therapy approaches combining ESWL with laser or ultrasound modalities are opening new pathways for treating complex stones with fewer complications.

Furthermore, the development of portable, compact, and lower-cost lithotripsy units is widening access among ambulatory surgical centers (ASCs) and smaller healthcare facilities. These cost-efficient devices reduce infrastructure needs, support higher procedure throughput, and make advanced stone management feasible in resource-constrained settings, ultimately expanding market penetration in both mature and emerging regions.

Product Insights

The extracorporeal lithotripsy devices segment is anticipated to dominate, accounting for 56.4% of the market share in 2026. Its leading position is supported by the non-invasive nature of extracorporeal shock wave lithotripsy (ESWL), shorter recovery times, and widespread use for kidney and ureteral stones. ESWL enables stone fragmentation without surgical access to the urinary tract, making it suitable for appropriately selected patients. Increasing preference for outpatient stone-management procedures, along with advances in shock-wave targeting, treatment planning, and real-time imaging, is further supporting adoption.

For example, modern ESWL platforms can integrate fluoroscopy or ultrasound-based stone localization to improve treatment accuracy. Hospitals and specialized urology centers are also upgrading aging systems with improved energy control, patient positioning, and automated targeting capabilities.

The intracorporeal lithotripsy devices segment is anticipated to register the fastest growth during the forecast period. Rising adoption of ureteroscopy is increasing demand for laser, pneumatic, and ultrasonic lithotripsy technologies.

For example, holmium and thulium fiber lasers are increasingly used to fragment or dust stones across different sizes and locations. Advances in flexible ureteroscopes, miniaturized instruments, and energy-delivery systems are further supporting their use in complex stone management.

Modality Insights

The standalone device segment is anticipated to dominate the market share in 2026, accounting for an anticipated revenue share of 54.7%. Its leading position is driven by high energy output, integrated imaging capabilities, robust construction, and treatment efficiency. Standalone platforms are particularly suited to hospitals and specialized urology centers handling high volumes of lithotripsy procedures.

These systems can integrate shock-wave generation, patient positioning, stone localization, and treatment controls within a dedicated platform. For example, advanced ESWL systems use fluoroscopy or ultrasound guidance to identify and track stones, while adjustable energy settings allow treatment parameters to be adapted to stone characteristics.

The portable device segment is anticipated to register the fastest growth during the forecast period. Expanding ambulatory care and the need to extend lithotripsy services to smaller healthcare facilities are driving adoption of compact systems.

For example, portable ESWL platforms can be deployed in specialty clinics and smaller urology centers where a dedicated lithotripsy suite may be impractical. Compact shock-wave generators, integrated imaging, mobile positioning systems, and digital controls are further improving portability and supporting adoption in emerging and decentralized healthcare settings.

North America Lithotripsy Devices Market Trends

North America is anticipated to dominate the global lithotripsy devices market, accounting for a 43.4% value share in 2026. The U.S. remains the primary contributor, supported by its advanced healthcare infrastructure, high adoption of minimally invasive procedures, and widespread availability of specialized urology and ambulatory surgery facilities. A large patient pool affected by kidney stones continues to support procedural demand for both extracorporeal shock wave lithotripsy and intracorporeal technologies.

U.S. Lithotripsy Devices Market Trends

The U.S. market benefits from strong technological adoption and continued investment in advanced stone-management platforms. Hospitals and urology centers are increasingly utilizing high-power laser systems and digitally enhanced technologies for complex stone procedures.

For example, Johnson & Johnson initiated enrollment in June 2026 for pivotal studies evaluating its purpose-built Shockwave SkyRunner Carotid IVL System, reflecting continued investment in expanding lithotripsy technology into new clinical applications. The broader development of advanced IVL platforms is strengthening the region's innovation ecosystem and supporting investment in next-generation energy-based treatment technologies.

Canada Lithotripsy Devices Market Trends

Canada contributes to regional demand through its established public healthcare infrastructure and growing focus on minimally invasive and outpatient treatment pathways. Access to advanced imaging and specialized urology services supports the use of extracorporeal and endoscopic lithotripsy systems.

The modernization of stone-management equipment and increasing availability of advanced laser technologies are expected to support replacement demand, particularly as healthcare providers seek platforms capable of improving procedural efficiency and reducing treatment complexity.

Europe Lithotripsy Devices Market Trends

Europe is anticipated to achieve steady growth, supported by rising kidney and ureteral stone prevalence, ageing populations, and increasing adoption of minimally invasive urology procedures. Well-developed healthcare systems and broad access to diagnostic imaging continue to support demand for extracorporeal and intracorporeal lithotripsy technologies. Product innovation is also expanding the range of energy-based treatment platforms available across the region.

Germany Lithotripsy Devices Market Trends

Germany remains an important European market due to its advanced hospital infrastructure and strong adoption of medical technology. The availability of specialized urology centers supports demand for modern laser and lithotripsy platforms.

Olympus' SOLTIVE Premium SuperPulsed Laser System, available through its European medical portfolio, demonstrates the shift toward technologies designed to improve stone dusting efficiency and reduce stone retropulsion during lithotripsy. Such innovations support the growing preference for precision-based intracorporeal stone treatment across European clinical settings.

U.K. Lithotripsy Devices Market Trends

The U.K. is benefiting from continued movement toward minimally invasive and day-care procedures. In September 2025, Johnson & Johnson launched the Shockwave Javelin Peripheral IVL Catheter in Europe, with physicians from Guy's and St Thomas' NHS Foundation Trust in London involved in highlighting its clinical application for difficult-to-cross calcified lesions. While focused on PAD rather than urinary stones, the launch demonstrates Europe's expanding adoption of catheter-based lithotripsy technologies and continued innovation in the broader lithotripsy device landscape.

Asia Pacific Lithotripsy Devices Market Trends

Asia Pacific is anticipated to register the fastest regional growth, with a CAGR of approximately 7.8% between 2026 and 2033. Rising urbanization, dietary changes, dehydration risks, and increasing obesity and diabetes rates are contributing to a growing stone-forming population. Improving healthcare infrastructure and greater investment in advanced imaging are expanding access to extracorporeal and intracorporeal lithotripsy procedures.

India Lithotripsy Devices Market Trends

India is emerging as a significant growth market due to expanding private hospital networks, increasing urology capacity, and rising demand for minimally invasive stone treatment. The growth of medical tourism is also encouraging hospitals to invest in advanced laser, imaging, and stone-management infrastructure. Demand for compact and cost-efficient lithotripsy systems is particularly relevant as providers expand specialized services beyond major metropolitan hospitals.

Japan Lithotripsy Devices Market Trends

Japan's advanced healthcare infrastructure and strong adoption of medical technologies support demand for sophisticated lithotripsy platforms. In May 2026, Johnson & Johnson announced that its next-generation Shockwave C2 Aero Coronary IVL Catheter was available in Japan, demonstrating the country's early adoption of advanced intravascular lithotripsy technology. Continued introduction of new IVL systems, alongside established demand for precision urology technologies, supports Japan's role as an important innovation-driven market within Asia Pacific.

The global lithotripsy devices market is highly competitive, with major players such as Siemens Healthineers AG, Dornier MedTech., Boston Scientific Corporation, STORZ MEDICAL AG, Inceler Medikal Ltd., and DirexGroup leveraging extensive product portfolios, advanced ESWL and intracorporeal lithotripsy technologies, and well-established international distribution networks.

Companies are increasingly prioritizing innovation in compact, portable, and digitally enhanced lithotripsy systems designed to improve treatment precision, reduce procedure time, and support both hospital and ambulatory surgical center workflows.

Market participants are actively investing in next-generation platforms that integrate AI-driven imaging, real-time stone tracking, automated targeting, and hybrid energy systems to enhance clinical outcomes and expand the treatable stone spectrum.

Strategic initiatives include mergers and acquisitions aimed at strengthening technological capabilities, partnerships with urology centers for clinical validation, and expansion into fast-growing regions such as the Asia Pacific and the Middle East.

Key Industry Developments:

• In October 2025, the FDA granted Breakthrough Device Designation to Avvio Medical’s Avvio enhanced lithotripsy system (ELS), a minimally invasive platform for treating ureteral stones. The device is currently being evaluated in a pivotal IDE study. The designation supports accelerated FDA review and closer regulatory guidance, recognizing the system’s potential to improve treatment safety and effectiveness. Avvio plans to submit a de novo application for device clearance in early 2026.
• In September 2025, Johnson & Johnson launched its Shockwave Javelin Peripheral IVL Catheter in Europe. The new intravascular lithotripsy system uses a single emitter placed near the catheter tip to improve calcium modification in severely narrowed vessels. With safety and performance similar to earlier Shockwave IVL devices, the launch strengthens the company’s leading PAD treatment portfolio.